Literature DB >> 18508936

Opa protein repertoires of disease-causing and carried meningococci.

Martin J Callaghan1, Caroline Buckee, Noel D McCarthy, Ana Belén Ibarz Pavón, Keith A Jolley, Saul Faust, Stephen J Gray, Edward B Kaczmarski, Michael Levin, J Simon Kroll, Martin C J Maiden, Andrew J Pollard.   

Abstract

The meningococcal Opa proteins play an important role in pathogenesis by mediating invasion of human cells. The aim of this investigation was to determine whether carried and disease-associated meningococci possess different Opa repertoires and whether the diversity of these proteins is associated with clinical severity of disease. Opa repertoires in 227 disease-associated meningococci, isolated in the United Kingdom over a period of 6 years, were compared to the repertoires in 190 asymptomatically carried meningococci isolated in the United Kingdom from a contemporary, nonepidemic period. Multidimensional scaling (MDS) was employed to investigate the association between Opa repertoires and multilocus sequence typing (MLST) genotypes. Associations with clinical severity were also analyzed statistically. High levels of diversity were observed in opa alleles, variable regions, and repertoires, and MDS revealed that MLST genotypes were strongly associated with particular Opa repertoires. Individual Opa proteins or repertoires were not associated with clinical severity, though there was a trend toward an association with the opaD locus. Meningococcal Opa repertoire is strongly linked to MLST genotype irrespective of epidemiological sampling and therefore correlates with invasiveness. It is not, however, strongly associated with severity of meningococcal disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18508936      PMCID: PMC2546767          DOI: 10.1128/JCM.00005-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  45 in total

1.  DAMBE: software package for data analysis in molecular biology and evolution.

Authors:  X Xia; Z Xie
Journal:  J Hered       Date:  2001 Jul-Aug       Impact factor: 2.645

2.  Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination.

Authors:  Martin C J Maiden; James M Stuart
Journal:  Lancet       Date:  2002-05-25       Impact factor: 79.321

Review 3.  Prospective validation of the Glasgow Meningococcal Septicaemia Prognostic Score. Comparison with other scoring methods.

Authors:  F Andrew I Riordan; Omnia Marzouk; Alistair P J Thomson; John A Sills; C Anthony Hart
Journal:  Eur J Pediatr       Date:  2002-08-17       Impact factor: 3.183

4.  Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity.

Authors:  Martin C J Maiden; Ana Belén Ibarz-Pavón; Rachel Urwin; Stephen J Gray; Nicholas J Andrews; Stuart C Clarke; A Mark Walker; Meirion R Evans; J Simon Kroll; Keith R Neal; Dlawer A A Ala'aldeen; Derrick W Crook; Kathryn Cann; Sarah Harrison; Richard Cunningham; David Baxter; Edward Kaczmarski; Jenny Maclennan; J Claire Cameron; James M Stuart
Journal:  J Infect Dis       Date:  2008-03-01       Impact factor: 5.226

5.  Neisserial binding to CEACAM1 arrests the activation and proliferation of CD4+ T lymphocytes.

Authors:  Ian C Boulton; Scott D Gray-Owen
Journal:  Nat Immunol       Date:  2002-02-19       Impact factor: 25.606

6.  Use of robotized DNA isolation and real-time PCR to quantify and identify close correlation between levels of Neisseria meningitidis DNA and lipopolysaccharides in plasma and cerebrospinal fluid from patients with systemic meningococcal disease.

Authors:  Reidun Øvstebø; Petter Brandtzaeg; Berit Brusletto; Kari Bente Foss Haug; Knut Lande; Ernst Arne Høiby; Peter Kierulf
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

7.  Activation of human dendritic cells is modulated by components of the outer membranes of Neisseria meningitidis.

Authors:  Tamara Al-Bader; Myron Christodoulides; John E Heckels; Judith Holloway; Amanda E Semper; Peter S Friedmann
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

8.  Conformational analysis of opacity proteins from Neisseria meningitidis.

Authors:  Marien I de Jonge; Martine P Bos; Hendrik J Hamstra; Wim Jiskoot; Peter van Ulsen; Jan Tommassen; Loek van Alphen; Peter van der Ley
Journal:  Eur J Biochem       Date:  2002-11

9.  Mapping the binding domains on meningococcal Opa proteins for CEACAM1 and CEA receptors.

Authors:  Marien I de Jonge; Hendrik Jan Hamstra; Loek van Alphen; Jacob Dankert; Peter van der Ley
Journal:  Mol Microbiol       Date:  2003-11       Impact factor: 3.501

Review 10.  Host genetic determinants of Neisseria meningitidis infections.

Authors:  M Emonts; J A Hazelzet; R de Groot; P W M Hermans
Journal:  Lancet Infect Dis       Date:  2003-09       Impact factor: 25.071

View more
  6 in total

1.  Persistence, replacement, and rapid clonal expansion of meningococcal carriage isolates in a 2008 university student cohort.

Authors:  Fadil A Bidmos; Keith R Neal; Neil J Oldfield; David P J Turner; Dlawer A A Ala'Aldeen; Christopher D Bayliss
Journal:  J Clin Microbiol       Date:  2010-12-01       Impact factor: 5.948

2.  Comparative genome biology of a serogroup B carriage and disease strain supports a polygenic nature of meningococcal virulence.

Authors:  Biju Joseph; Susanne Schneiker-Bekel; Anja Schramm-Glück; Jochen Blom; Heike Claus; Burkhard Linke; Roland F Schwarz; Anke Becker; Alexander Goesmann; Matthias Frosch; Christoph Schoen
Journal:  J Bacteriol       Date:  2010-08-13       Impact factor: 3.490

3.  Opa+ and Opa- isolates of Neisseria meningitidis and Neisseria gonorrhoeae induce sustained proliferative responses in human CD4+ T cells.

Authors:  Abdel-Rahman Youssef; Michiel van der Flier; Silvia Estevão; Nico G Hartwig; Peter van der Ley; Mumtaz Virji
Journal:  Infect Immun       Date:  2009-08-31       Impact factor: 3.441

Review 4.  How the Knowledge of Interactions between Meningococcus and the Human Immune System Has Been Used to Prepare Effective Neisseria meningitidis Vaccines.

Authors:  R Gasparini; D Panatto; N L Bragazzi; P L Lai; A Bechini; M Levi; P Durando; D Amicizia
Journal:  J Immunol Res       Date:  2015-08-17       Impact factor: 4.818

5.  The biology of Neisseria adhesins.

Authors:  Miao-Chiu Hung; Myron Christodoulides
Journal:  Biology (Basel)       Date:  2013-07-29

6.  Construction of Opa-positive and Opa-negative strains of Neisseria meningitidis to evaluate a novel meningococcal vaccine.

Authors:  Manish Sadarangani; J Claire Hoe; Martin J Callaghan; Claire Jones; Hannah Chan; Katherine Makepeace; Hélène Daniels-Treffandier; Mary E Deadman; Christopher Bayliss; Ian Feavers; Peter van der Ley; Andrew J Pollard
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.